Towards Healthcare
Gene Therapy Market Size Hits USD 11.4 Billion in 2025

Gene Therapy Market in 2025 Hospitals Lead with 65% Share as R&D

Market insights predict the global gene therapy industry will increase from USD 9.5 billion in 2024 to USD 58.87 billion by 2034, achieving a CAGR of 20%. The gene therapy market is growing rapidly due to the growing demand for precision medicine. North America’s dominance is attributed to the rising focus on genomics & multi-omics.

Content

  • Last Updated: 08 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The gene therapy market is projected to reach USD 58.87 billion by 2034, growing at a CAGR of 20% from 2024 to 2034.

North America is currently leading the gene therapy market due to rising cases of chronic conditions and growing investments in multi-omics.

The gene therapy market includes seven segments such as by therapy type, by vector type, by gene type, by disease indication, by delivery method, by end-user, and by region.

Some key players include Amgen Inc., Novartis AG, F. Hoffmann-La Roche, Gilead Sciences, Inc., bluebird bio, Inc., etc.

Key trends include rising prevalence of cancer, growing demand for personalized medicine, and rising research in genomics.

By repairing the underlying genetic fault, gene therapy may provide a permanent cure for certain genetic disorders. however, the effectiveness of this treatment will vary depending on the condition, the mode of administration, and the stability of the implanted gene.

By 2036, genetic treatments are predicted to be the norm for treating uncommon genetic disorders, and they will finally be able to cure them.  Additionally, CRISPR-Cas9 is thought to be the most promising gene editing technique for replacing or repairing damaged genes within the next 15 years.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions